Precision Medicine Market
According to Intent Market Research, the Precision Medicine Market is expected to grow from USD 30.7 billion in 2023-e at a CAGR of 11.4% to touch USD 59.3 billion by 2030. The precision medicine market is competitive, the prominent players in the global market include AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Catalent, Eli Lilly, Gilead Sciences, Johnson & Johnson, Lonza, Merck, Novartis, Parexel, Pfizer, Roche, Sanofi, Takeda Pharmaceutical, amongst others.